These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 28732393

  • 21. miR-589-5p inhibits MAP3K8 and suppresses CD90+ cancer stem cells in hepatocellular carcinoma.
    Zhang X, Jiang P, Shuai L, Chen K, Li Z, Zhang Y, Jiang Y, Li X.
    J Exp Clin Cancer Res; 2016 Nov 11; 35(1):176. PubMed ID: 27835990
    [Abstract] [Full Text] [Related]

  • 22. Overexpression of miR-623 suppresses progression of hepatocellular carcinoma via regulating the PI3K/Akt signaling pathway by targeting XRCC5.
    Ren F, Su H, Jiang H, Chen Y.
    J Cell Biochem; 2020 Jan 11; 121(1):213-223. PubMed ID: 31190447
    [Abstract] [Full Text] [Related]

  • 23. microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit.
    Shi X, Liu TT, Yu XN, Balakrishnan A, Zhu HR, Guo HY, Zhang GC, Bilegsaikhan E, Sun JL, Song GQ, Weng SQ, Dong L, Ott M, Zhu JM, Shen XZ.
    Oncogene; 2020 Aug 11; 39(35):5768-5781. PubMed ID: 32719439
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. MiR-29a suppresses cell proliferation by targeting SIRT1 in hepatocellular carcinoma.
    Zhang Y, Yang L, Wang S, Liu Z, Xiu M.
    Cancer Biomark; 2018 Aug 11; 22(1):151-159. PubMed ID: 29630527
    [Abstract] [Full Text] [Related]

  • 28. PRMT6 Regulates RAS/RAF Binding and MEK/ERK-Mediated Cancer Stemness Activities in Hepatocellular Carcinoma through CRAF Methylation.
    Chan LH, Zhou L, Ng KY, Wong TL, Lee TK, Sharma R, Loong JH, Ching YP, Yuan YF, Xie D, Lo CM, Man K, Artegiani B, Clevers H, Yan HH, Leung SY, Richard S, Guan XY, Huen MSY, Ma S.
    Cell Rep; 2018 Oct 16; 25(3):690-701.e8. PubMed ID: 30332648
    [Abstract] [Full Text] [Related]

  • 29. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L, Beckebaum S, Iacob S, Wu G, Kaiser GM, Radtke A, Liu C, Kabar I, Schmidt HH, Zhang X, Lu M, Cicinnati VR.
    J Hepatol; 2014 Mar 16; 60(3):590-8. PubMed ID: 24211739
    [Abstract] [Full Text] [Related]

  • 30. MicroRNA-294 Promotes Cell Proliferation, Migration and Invasion in SMMC-7721 Hepatoma Carcinoma Cells by Activating the JNK/ERK Signaling Pathway.
    Cheng X, Chen M, Liu Z.
    Am J Med Sci; 2020 Jun 16; 359(6):365-371. PubMed ID: 32498943
    [Abstract] [Full Text] [Related]

  • 31. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
    Wu G, Zheng K, Xia S, Wang Y, Meng X, Qin X, Cheng Y.
    J Exp Clin Cancer Res; 2016 Jun 04; 35(1):89. PubMed ID: 27259866
    [Abstract] [Full Text] [Related]

  • 32. Neuroglobin, a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk.
    Zhang J, Lan SJ, Liu QR, Liu JM, Chen XQ.
    Mol Pharmacol; 2013 May 04; 83(5):1109-19. PubMed ID: 23478801
    [Abstract] [Full Text] [Related]

  • 33. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.
    Yu J, Yang M, Zhou B, Luo J, Zhang Z, Zhang W, Yan Z.
    Clin Sci (Lond); 2019 Jul 15; 133(13):1487-1503. PubMed ID: 31278132
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. MicroRNA-30a-3p inhibits malignant progression of hepatocellular carcinoma through regulating IGF1.
    Wei YY, Ren TL.
    Eur Rev Med Pharmacol Sci; 2020 Dec 15; 24(23):12144-12152. PubMed ID: 33336732
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target.
    Qin CD, Ma DN, Zhang SZ, Zhang N, Ren ZG, Zhu XD, Jia QA, Chai ZT, Wang CH, Sun HC, Tang ZY.
    Cell Death Dis; 2018 May 01; 9(5):486. PubMed ID: 29706627
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of long noncoding RNA cancer susceptibility candidate 7 attenuates hepatocellular carcinoma development by targeting microRNA-30a-5p.
    Li D, Lu L, Liu M, Sun J.
    Bioengineered; 2022 Apr 01; 13(4):11296-11308. PubMed ID: 35484972
    [Abstract] [Full Text] [Related]

  • 39. Long non-coding RNA SNHG16 regulates cell behaviors through miR-542-3p/HNF4α axis via RAS/RAF/MEK/ERK signaling pathway in pediatric neuroblastoma cells.
    Deng D, Yang S, Wang X.
    Biosci Rep; 2020 May 29; 40(5):. PubMed ID: 32412051
    [Abstract] [Full Text] [Related]

  • 40. Correlation of LAGE3 with unfavorable prognosis and promoting tumor development in HCC via PI3K/AKT/mTOR and Ras/RAF/MAPK pathways.
    Li Y, Xiong H.
    BMC Cancer; 2022 Mar 21; 22(1):298. PubMed ID: 35313850
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.